Skip to main content

Juror Steps Forward To Defend $80M on Roundup Verdict

Juror Steps Forward To Defend $80M on Roundup Verdict

Juror Steps Forward To Defend $80M on Roundup Verdict

Introduction

A juror who supported the $80 million award to a plaintiff against Bayer acquired Monsanto came forward to defend the panel’s decision. The defendant told a California federal judge that an unfair trial led to its $80M loss in Roundup bellwether trial stating that the juror, who recently wrote a letter urging the judge to preserve the award, was seen hugging the plaintiff at a post-trial hearing.

The defendant stated that Juror #5 should not have been selected as she showed a bias behavior against them before the trial. According to the letter posted on the court’s website on July 4, the juror insisted the damage awards “were no accident” and reflected the jury's meticulous planning. The juror also made a note that higher punitive damages were sometimes permitted in extraordinary cases.

The plaintiff used Roundup for more than 30 years and was diagnosed with non-Hodgkin's lymphoma in 2014. In March the U.S. District Court, Northern District of California, awarded plaintiff with $5M in compensation and $75M in punitive damages. The defendant denied glyphosate caused cancer and insisted the jury’s decision was unwarranted.

Bayer and its Monsanto subsidiary, acquired a year ago, now face more than 15,000 Roundup lawsuits. U.S. District Judge Vince Chhabria is presiding over all the federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!